113 related articles for article (PubMed ID: 2215058)
21. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
22. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
23. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro.
Ottenhoff TH; Wondimu A; Reddy NN
Scand J Immunol; 1990 May; 31(5):553-65. PubMed ID: 2111939
[TBL] [Abstract][Full Text] [Related]
24. Leukocyte antimicrobial function in patients with leprosy.
Drutz DJ; Cline MJ; Levy L
J Clin Invest; 1974 Feb; 53(2):380-6. PubMed ID: 11344550
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862
[TBL] [Abstract][Full Text] [Related]
26. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
27. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
28. A histopathological and immunological profile of a single lesion lepromatous leprosy (LLs).
Misra RS; Ravi S; Iyengar B; Nath I
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):645-8. PubMed ID: 1802946
[No Abstract] [Full Text] [Related]
29. The post-lepromin scar and its significance in the control of HD.
Walter J
Indian J Lepr; 1989 Jul; 61(3):379-86. PubMed ID: 2527921
[TBL] [Abstract][Full Text] [Related]
30. CLINICAL EVALUATION STUDIES IN LEPROMATOUS LEPROSY. FIFTH SERIES: DIETHYL DITHIOLISOPHTHALATE (ETISUL) AS A SUPPLEMENT TO 4-4' DIAMINODIPHENYL SULFONE (DDS).
DOULL JA; TOLENTINO JG; RODRIGUEZ JN; GUINTO RS; RIVERA JN; FERNANDEZ JV; MABALAY MC
Int J Lepr; 1965; 33():186-205. PubMed ID: 14339337
[No Abstract] [Full Text] [Related]
31. Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines.
Douglas JT; Hirsch DS; Fajardo TT; Cellona RV; Abalos RM; de la Cruz EC; Madarang MG; de Wit MY; Klatser PR
Lepr Rev; 1989 Mar; 60(1):8-19. PubMed ID: 2657302
[TBL] [Abstract][Full Text] [Related]
32. Infection by Mycobacterium leprae of household contacts of lepromatous leprosy patients from a post-elimination leprosy region of Colombia.
Cardona-Castro NM; Restrepo-Jaramillo S; Gil de la Ossa M; Brennan PJ
Mem Inst Oswaldo Cruz; 2005 Nov; 100(7):703-7. PubMed ID: 16410954
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
[TBL] [Abstract][Full Text] [Related]
34. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
35. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines.
Klatser PR; de Wit MY; Fajardo TT; Cellona RV; Abalos RM; de la Cruz EC; Madarang MG; Hirsch DS; Douglas JT
Lepr Rev; 1989 Sep; 60(3):178-86. PubMed ID: 2682104
[TBL] [Abstract][Full Text] [Related]
38. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
Convit J; Aranzazu N; Pinardi M; Ulrich M
Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
[TBL] [Abstract][Full Text] [Related]
39. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
40. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
